Department of Molecular Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, MB110, La Jolla, CA 92037, USA; Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
Department of Molecular Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, MB110, La Jolla, CA 92037, USA.
Cell Chem Biol. 2019 Jul 18;26(7):913-925.e4. doi: 10.1016/j.chembiol.2019.04.001. Epub 2019 May 16.
Activation of the unfolded protein response (UPR)-associated transcription factor ATF6 has emerged as a promising strategy to reduce the secretion and subsequent toxic aggregation of destabilized, amyloidogenic proteins implicated in systemic amyloid diseases. However, the molecular mechanism by which ATF6 activation reduces the secretion of amyloidogenic proteins remains poorly defined. We employ a quantitative interactomics platform to define how ATF6 activation reduces secretion of a destabilized, amyloidogenic immunoglobulin light chain (LC) associated with light-chain amyloidosis (AL). Using this platform, we show that ATF6 activation increases the targeting of this destabilized LC to a subset of pro-folding ER proteostasis factors that retains the amyloidogenic LC within the ER, preventing its secretion. Our results define a molecular basis for the ATF6-dependent reduction in destabilized LC secretion and highlight the advantage for targeting this UPR-associated transcription factor to reduce secretion of destabilized, amyloidogenic proteins implicated in AL and related systemic amyloid diseases.
未折叠蛋白反应 (UPR) 相关转录因子 ATF6 的激活已成为一种很有前途的策略,可以减少与系统性淀粉样疾病相关的不稳定、淀粉样的蛋白质的分泌和随后的毒性聚集。然而,ATF6 激活减少淀粉样蛋白质分泌的分子机制仍未明确定义。我们采用定量相互作用组学平台来定义 ATF6 激活如何减少与轻链淀粉样变性 (AL) 相关的不稳定、淀粉样的免疫球蛋白轻链 (LC) 的分泌。使用该平台,我们表明 ATF6 激活增加了将这种不稳定的 LC 靶向一组促进折叠的 ER 蛋白稳态因子,这些因子将淀粉样 LC 保留在 ER 内,防止其分泌。我们的结果定义了 ATF6 依赖性降低不稳定 LC 分泌的分子基础,并强调了靶向这种与 UPR 相关的转录因子以减少与 AL 和相关系统性淀粉样疾病相关的不稳定、淀粉样蛋白质分泌的优势。